Panzyga Solution
Product Images NDC 68982-822

9 FDA label images from Octapharma Usa Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Panzyga (NDC 68982-822). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Octapharma Usa Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image File (Img0001)

Image File (Img0001)
A data table showing virus reduction factors (log10) for Panzyga production steps against enveloped viruses (HIV-1, PRV, BVDV) and non-enveloped viruses (MEV, PPV). It lists values for S/D treatment, Ion-exchange chromatography, Nanofiltration (20 nm), and the global reduction factor for each virus type.*
FDA Label Image

Image File (Img0002)

Image File (Img0002)
A pharmacokinetic data table for Panzyga (immune globulin intravenous), showing baseline uncorrected and baseline corrected parameters across four age groups: 0 to less than 6 years, 6 to less than 12 years, 12 to less than 16 years, and 16 to 75 years. Parameters include Cmax, AUC (0-tau), CL, Vss, and half-life, with mean values and standard deviations listed for each group and parameter.*
FDA Label Image

Image File (Img0003)

Image File (Img0003)
A data table comparing pharmacokinetic parameters by age group for Panzyga (immune globulin intravenous (human)) at 100 mg/mL strength. Parameters include Cmax, AUC, clearance, volume of distribution, and half-life, presented separately for baseline uncorrected and baseline corrected values across four age groups from 0 to 75 years.*
FDA Label Image

Image File (Img0004)

Image File (Img0004)
The image shows the packaging label for Panzyga, an immune globulin intravenous (human) 10% solution, with a strength of 1 g/10 mL. It is labeled for intravenous infusion, solvent/detergent treated and nanofiltered, manufactured by Octapharma and distributed by Octapharma USA Inc. The label includes storage, product composition, and contact information details.*
FDA Label Image

Image File (Img0005)

Image File (Img0005)
Carton packaging label for Panzyga 2.5 g/25 mL, an intravenous immune globulin solution (human) by Octapharma USA Inc. The label indicates the product is solvent/detergent treated and nanofiltered, for intravenous infusion only, and prescription use. The label includes storage instructions, manufacturer details, and a barcode.*
FDA Label Image

Image File (Img0006)

Image File (Img0006)
Carton label for Panzyga immune globulin intravenous (human) solution, 5 g per 50 mL, 100 mg/mL concentration. The label includes storage instructions, manufacturer Octapharma USA Inc, as well as batch and expiration details. It states the product is solvent/detergent treated and nanofiltered for intravenous infusion use only. The label also highlights protein content and the absence of preservatives.*
FDA Label Image

Image File (Img0007)

Image File (Img0007)
Panzyga 10 g/100 mL immune globulin intravenous (human) solution packaging label by Octapharma USA Inc. The label includes storage instructions, manufacturer and distributor information, protein content per mL, and usage notes. The product is solvent/detergent treated and nanofiltered for intravenous infusion only.*
FDA Label Image

Image File (Img0008)

Image File (Img0008)
Panzyga 20 g/200 mL Immune Globulin Intravenous (Human) – ifas 10% solution for intravenous infusion. The carton displays product strength, dosage form, and manufacturer Octapharma USA Inc. It includes storage instructions, product composition per mL, and regulatory information such as U.S. license and distributor contact details. The label emphasizes that the product is solvent/detergent treated and nanofiltered.*
FDA Label Image

Image File (Img0009)

Image File (Img0009)
The packaging label for Panzyga immune globulin intravenous (human) solution, 30 g per 300 mL (10%) strength. The label shows it is a solvent/detergent treated and nanofiltered plasma derivative for intravenous infusion only. Manufactured by Octapharma Pharmazeutika in Austria and distributed by Octapharma USA Inc. The label includes storage instructions, protein content per mL, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.